SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

The SPDR Gold Shares ETF (GLD) is experiencing a period of intense volatility as traders weigh the complex interaction between geopolitical risk from the Iran conflict, rising energy costs, and a strengthening U.S. dollar. Community sentiment is deeply divided, with many market participants expressing frustration over the lack of a traditional safe-haven rally while others view the pullback as a strategic accumulation opportunity ahead of anticipated long-term inflationary pressures.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is experiencing significant volatility as investors weigh a blowout earnings report and record-breaking guidance against concerns over increased capital expenditures and broader market risk-off sentiment. While the community remains deeply divided between bulls citing the AI-driven memory supercycle and bears warning of a potential peak in the semiconductor cycle, institutional analysts have responded to the strong results with a wave of major price target upgrades.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is seeing significant market activity as investors and the community weigh potential M&A rumors against the company's strong revenue growth and expanded pipeline. Traders are closely monitoring heavy trading volumes and institutional positioning, with many discussing whether these signs indicate an imminent buyout or a long-term growth play for the rare-disease specialist.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as the community eagerly anticipates the full launch of its Super App and potential major institutional partnerships, often compared by retail investors to the utility of Ripple and Stellar. While some holders express frustration over recent price volatility and token unlock schedules, active community members are focusing on long-term accumulation, viewing the current market cycle as a prime opportunity to build positions before broader regulatory developments unfold.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending following a massive sell-off triggered by concerns that Anthropic's new Claude Code tool could automate the modernization of COBOL systems, potentially disrupting a core revenue stream for the company. Despite the volatility and aggressive put-side betting, the community is actively debating whether this is a structural threat or a temporary overreaction, with many bulls emphasizing IBM's entrenched enterprise position and ongoing investments in hybrid cloud and quantum computing as long-term support.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is facing intense market volatility following a major partnership announcement with Uber, which plans to deploy a fleet of autonomous R2 robotaxis by 2028. While some community members view the deal as a long-term validation of Rivian's autonomous stack and manufacturing strategy, others are skeptical, citing concerns over production timelines, potential liquidity risks, and broader market pressure on the EV sector.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

SLV is currently trending due to intense volatility and investor debate following a significant price retrace, with the community clashing over whether the current weakness is a result of market manipulation and central bank liquidity management or a standard healthy correction after an extended parabolic run. Discussions are heavily focused on the disconnect between the ETF price action and physical market demand, with many traders debating if this is a temporary dip to be bought or a deeper structural trend change driven by broader macroeconomic factors like interest rate expectations and geopolitical tension.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is seeing heightened investor attention as the company announced an expansion of its share repurchase program to $300 million alongside a new $750 million credit facility, signaling strong financial flexibility and management's confidence. While the community is actively debating the timing of these buybacks and the potential for a strategic buyout or business development move, many remain focused on the long-term growth of Briumvi as a catalyst for future share price appreciation.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is surging as investors pivot to the company for energy security following escalating conflict in the Middle East that has disrupted global LNG supply chains and effectively closed the Strait of Hormuz. The community is actively discussing the stock's role as a primary beneficiary of surging spot prices, while the recent closing of major project financing and positive analyst commentary fuel expectations for a breakout toward previous highs.

GhostwareOS (GHOST) is the Full-Stack Privacy Layer of Solana — a next-generation AI-driven infrastructure for encrypted communication, anonymous identity management, and untraceable transactions. By combining advanced zero-knowledge protocols with autonomous AI routing, GhostwareOS allows users and developers to operate invisibly across Web3. It powers decentralized apps that demand true digital anonymity, scalable privacy, and zero metadata leakage — restoring control to users in an overexposed internet age.

Ghost

Ghost Crypto is generating intense debate as community members push its identity as the "Privacy Layer of Solana," while skeptics label the volatile asset a pump-and-dump scheme. Investors are currently hyper-focused on upcoming ecosystem developments, potential exchange listings, and the project's ability to maintain momentum amidst a broader market rotation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Adaptive Biotechnologies (NASDAQ:ADPT) COO Julie Rubinstein Sells 19,060 Shares

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) COO Julie Rubinstein sold 19,060 shares of the company's stock in a transaction on Wednesday, March 18th. The shares were sold at an average price of $13.18, for a total value of $251,210.80. Following the completion of the...

Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells $255,594.60 in Stock

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) COO Julie Rubinstein sold 19,060 shares of Adaptive Biotechnologies stock in a transaction dated Monday, March 16th. The stock was sold at an average price of $13.41, for a total value of $255,594.60. Following the sale, the chief...

Adaptive Biotechnologies Corporation $ADPT Shares Bought by Algert Global LLC

Algert Global LLC raised its holdings in Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Free Report) by 215.7% in the third quarter, according to the company in its most recent disclosure with...

Adaptive Biotechnologies (NASDAQ:ADPT) Sees Unusually-High Trading Volume - Here's Why

Adaptive Biotechnologies (NASDAQ:ADPT) Sees Unusually-High Trading Volume - Still a Buy...

Iron Triangle Partners LP Purchases 325,032 Shares of Adaptive Biotechnologies Corporation $ADPT

Iron Triangle Partners LP increased its position in shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Free Report) by 21.7% during the 3rd quarter, according to its most recent Form 13F...

Adaptive Biotechnologies (ADPT) Moves 5.8% Higher: Will This Strength Last?

Adaptive Biotechnologies (ADPT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Fred Alger Management LLC Has $37.61 Million Stock Holdings in Adaptive Biotechnologies Corporation $ADPT

Fred Alger Management LLC lifted its holdings in shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Free Report) by 6.7% during the 3rd quarter, according to the company in its most recent...

Adaptive Biotechnologies Corporation $ADPT Shares Sold by Braidwell LP

Braidwell LP decreased its position in shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Free Report) by 80.9% during the 3rd quarter, according to the company in its most recent Form 13F...

Aristotle Atlantic Partners LLC Acquires 247,402 Shares of Adaptive Biotechnologies Corporation $ADPT

Aristotle Atlantic Partners LLC grew its stake in Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Free Report) by 8.6% during the 3rd quarter, according to the company in its most recent 13F...

Adaptive Biotechnologies (NASDAQ:ADPT) Insider Sells $831,066.51 in Stock

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) insider Sharon Benzeno sold 63,103 shares of the company's stock in a transaction dated Wednesday, March 11th. The shares were...

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.

ADPT
Adaptive Biotechnologies Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ADPT News

ADPTAdaptive Biotechnologies Corp